
Nyxoah S.A. – NASDAQ:NYXH
Nyxoah S.A. stock price today
Nyxoah S.A. stock price monthly change
Nyxoah S.A. stock price quarterly change
Nyxoah S.A. stock price yearly change
Nyxoah S.A. key metrics
Market Cap | 274.88M |
Enterprise value | 129.31M |
P/E | -5.8 |
EV/Sales | 65.31 |
EV/EBITDA | -6.07 |
Price/Sales | 88.84 |
Price/Book | 1.32 |
PEG ratio | 0.08 |
EPS | -1.52 |
Revenue | 5.12M |
EBITDA | -43.04M |
Income | -43.20M |
Revenue Q/Q | 176.87% |
Revenue Y/Y | 78.98% |
Profit margin | -1348.13% |
Oper. margin | -1591.92% |
Gross margin | 61.21% |
EBIT margin | -1591.92% |
EBITDA margin | -839.43% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNyxoah S.A. stock price history
Nyxoah S.A. stock forecast
Nyxoah S.A. financial statements
$17
Potential upside: 166.04%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 1.10M | -12.79M | -1156.01% |
---|---|---|---|
Sep 2023 | 976K | -7.61M | -779.92% |
Dec 2023 | 1.82M | -10.89M | -597.2% |
Mar 2024 | 1.22M | -11.90M | -975.1% |
Jun 2023 | 142412000 | 26.83M | 18.84% |
---|---|---|---|
Sep 2023 | 134601000 | 26.05M | 19.36% |
Dec 2023 | 124157000 | 26.04M | 20.98% |
Mar 2024 | 113016000 | 25.64M | 22.69% |
Jun 2023 | -11.81M | -7.48M | 2.41M |
---|---|---|---|
Sep 2023 | -10.62M | 7.36M | -220K |
Dec 2023 | -13.27M | 22.14M | -501K |
Mar 2024 | -11.53M | 11.88M | -245K |
Nyxoah S.A. alternative data
Aug 2023 | 137 |
---|---|
Sep 2023 | 137 |
Oct 2023 | 137 |
Nov 2023 | 137 |
Dec 2023 | 137 |
Jan 2024 | 137 |
Feb 2024 | 137 |
Mar 2024 | 137 |
Apr 2024 | 137 |
May 2024 | 146 |
Jun 2024 | 146 |
Jul 2024 | 146 |
Nyxoah S.A. other data
Quarter | Transcript |
---|---|
Q4 2023 5 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 11 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 16 May 2023 | Q1 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Olivier Taelman (1971) Chief Executive Officer & Executive Director | $379,670 |
Mr. Robert Taub MBA (1947) Co-Founder & Chairman | $87,320 |
-
What's the price of Nyxoah S.A. stock today?
One share of Nyxoah S.A. stock can currently be purchased for approximately $6.39.
-
When is Nyxoah S.A.'s next earnings date?
Unfortunately, Nyxoah S.A.'s (NYXH) next earnings date is currently unknown.
-
Does Nyxoah S.A. pay dividends?
No, Nyxoah S.A. does not pay dividends.
-
How much money does Nyxoah S.A. make?
Nyxoah S.A. has a market capitalization of 274.88M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 40.99% to 4.35M US dollars.
-
What is Nyxoah S.A.'s stock symbol?
Nyxoah S.A. is traded on the NASDAQ under the ticker symbol "NYXH".
-
What is Nyxoah S.A.'s primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Nyxoah S.A.?
Shares of Nyxoah S.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nyxoah S.A.'s key executives?
Nyxoah S.A.'s management team includes the following people:
- Mr. Olivier Taelman Chief Executive Officer & Executive Director(age: 54, pay: $379,670)
- Mr. Robert Taub MBA Co-Founder & Chairman(age: 78, pay: $87,320)
-
Is Nyxoah S.A. founder-led company?
Yes, Nyxoah S.A. is a company led by its founder Mr. Robert Taub MBA.
-
How many employees does Nyxoah S.A. have?
As Jul 2024, Nyxoah S.A. employs 146 workers, which is 7% more then previous quarter.
-
When Nyxoah S.A. went public?
Nyxoah S.A. is publicly traded company for more then 4 years since IPO on 28 Apr 2021.
-
What is Nyxoah S.A.'s official website?
The official website for Nyxoah S.A. is nyxoah.com.
-
How can i contact Nyxoah S.A.?
Nyxoah S.A. can be reached via phone at +32 10 22 23 55.
-
What is Nyxoah S.A. stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Nyxoah S.A. in the last 12 months, the avarage price target is $17. The average price target represents a 166.04% change from the last price of $6.39.
Nyxoah S.A. company profile:

Nyxoah S.A.
nyxoah.comNASDAQ
146
Medical - Instruments & Supplies
Healthcare
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Mont-Saint-Guibert, 1435
CIK: 0001857190
ISIN: BE0974358906
: